Report ID |
98371 |
Drug Identification Number |
02049481 |
Brand name |
NOVAHISTEX DH |
Common or Proper name |
Novahistex DH |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
PHENYLEPHRINE HYDROCHLORIDE
HYDROCODONE BITARTRATE |
Strength(s) |
20MG
5MG |
Dosage form(s) |
SYRUP |
Route of administration |
ORAL |
Packaging size |
100ml |
ATC code |
R05DA |
ATC description |
COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for discontinuation |
Business reasons |
Anticipated discontinuation date |
2020-03-31 |
Actual discontinuation date |
2020-04-09 |
Remaining supply date |
2020-03-31 |
Discontinuation status |
Discontinued |
Discontinuation decision reversal |
No |
Information on remaining supply |
|
Company comments |
last lot 8131851 expiry 2022-05-29 |
Health Canada comments |
|
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |